Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lenalidomide long-term neurotoxicity: Clinical and neurophysiologic prospective study.
Dalla Torre C, Zambello R, Cacciavillani M, Campagnolo M, Berno T, Salvalaggio A, De March E, Barilà G, Lico A, Lucchetta M, Ermani M, Briani C. Dalla Torre C, et al. Among authors: lico a. Neurology. 2016 Sep 13;87(11):1161-6. doi: 10.1212/WNL.0000000000003093. Epub 2016 Aug 17. Neurology. 2016. PMID: 27534712
Diffusion-weighted whole-body MRI for evaluation of early response in multiple myeloma.
Lacognata C, Crimì F, Guolo A, Varin C, De March E, Vio S, Ponzoni A, Barilà G, Lico A, Branca A, De Biasi E, Gherlinzoni F, Scapin V, Bissoli E, Berno T, Zambello R. Lacognata C, et al. Among authors: lico a. Clin Radiol. 2017 Oct;72(10):850-857. doi: 10.1016/j.crad.2017.05.004. Epub 2017 Jun 3. Clin Radiol. 2017. PMID: 28587715
A real-world retrospective-prospective analysis of efficacy and safety of combined ixazomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma: The northern Italy experience.
Furlan A, Cea M, Pavan L, Galli M, Clissa C, Mangiacavalli S, Cafro AM, Girlanda S, Patriarca F, Minotto C, Bertoldero G, Barilà G, Pascarella A, Lico A, Paolini R, Rabassi N, Pescosta N, Porrazzo M, De Sabbata G, Pompa A, Bega G, Cavallin S, Guidotti F, Marcatti M, Rupolo M, Belotti A, Gherlinzoni F, Zambello R. Furlan A, et al. Among authors: lico a. Cancer Med. 2024 Apr;13(7):e7071. doi: 10.1002/cam4.7071. Cancer Med. 2024. PMID: 38558233 Free PMC article.
A real-life study of daratumumab-bortezomib-dexamethasone (D-VD) in lenalidomide exposed/refractory multiple myeloma patients: a report from the Triveneto Myeloma Working Group.
Barilà G, Quaglia FM, Furlan A, Pescosta N, Bonalumi A, Marcon C, Pascarella A, Tinelli M, De March E, Lico A, Sartori R, Clissa C, De Sabbata G, Nappi D, Porrazzo M, De Marchi R, Pavan L, Tosetto A, Gherlinzoni F, Krampera M, Bassan R, Patriarca F, Semenzato G, Zambello R. Barilà G, et al. Among authors: lico a. Ann Hematol. 2024 Jan;103(1):125-132. doi: 10.1007/s00277-023-05443-8. Epub 2023 Sep 20. Ann Hematol. 2024. PMID: 37731147 Free PMC article.
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
De Bellis E, Imbergamo S, Candoni A, Liço A, Tanasi I, Mauro E, Mosna F, Leoncin M, Stulle M, Griguolo D, Pravato S, Trentin L, Lazzarotto D, Di Bona E, Sancetta R, Lucchini E, Poiani M, Palmieri C, Zaja F. De Bellis E, et al. Among authors: lico a. Leuk Res. 2022 Apr;115:106811. doi: 10.1016/j.leukres.2022.106811. Epub 2022 Feb 24. Leuk Res. 2022. PMID: 35219543 No abstract available.
Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience.
De Bellis E, Imbergamo S, Candoni A, Liço A, Tanasi I, Mauro E, Mosna F, Leoncin M, Stulle M, Griguolo D, Pravato S, Trentin L, Lazzarotto D, Di Bona E, Bassan R, Lucchini E, Poiani M, Palmieri C, Zaja F. De Bellis E, et al. Among authors: lico a. Leuk Res. 2022 Mar;114:106803. doi: 10.1016/j.leukres.2022.106803. Epub 2022 Feb 8. Leuk Res. 2022. PMID: 35150967 Free article.
Identification of the true hyperdiploid multiple myeloma subset by combining conventional karyotyping and FISH analysis.
Barilà G, Bonaldi L, Grassi A, Martines A, Liço A, Macrì N, Nalio S, Pavan L, Berno T, Branca A, Calabretto G, Carrino M, Teramo A, Manni S, Piazza F, Semenzato G, Zambello R. Barilà G, et al. Among authors: lico a. Blood Cancer J. 2020 Feb 17;10(2):18. doi: 10.1038/s41408-020-0285-6. Blood Cancer J. 2020. PMID: 32066724 Free PMC article. No abstract available.
Severe infections unrelated to neutropenia impact on overall survival in multiple myeloma patients: results of a single centre cohort study.
Barilà G, Compagno N, Liço A, Berno T, Bonaldi L, Teramo A, Manni S, Branca A, Frigo AC, Cinetto F, Piazza F, Semenzato G, Zambello R. Barilà G, et al. Among authors: lico a. Br J Haematol. 2019 Aug;186(3):e13-e17. doi: 10.1111/bjh.15849. Epub 2019 Mar 10. Br J Haematol. 2019. PMID: 30854624 Free article. No abstract available.
13 results